Cases of late-stage prostate cancer are on the rise as screenings decline

Advanced prostate cancer rates are on the rise in men over 50, while rates of early stage prostate cancer have declined. The US Preventive Services Task Force issued recommendations against prostate screenings for all in 2012, because the risks of the test outweighed the benefits. Prostate cancer is one of the most common types of cancer for men. Visit Business Insider’s homepage for more stories.

A new study published in the Journal of the National Cancer Institute examined what happened five years after the US Preventive Services Task Force issued recommendations against prostate screenings for men. For